Restor3d announced today that it completed its previously announced acquisition of Conformis (Nasdaq:CFMS). The companies completed the deal, announced in June, after Conformis’ stockholders approved it at a special meeting on Aug. 31. As a result, shares of Conformis common stock ceased trading on the Nasdaq prior to market open today, Sept. 5. Per the […]
Restor3d
Restor3d to acquire Conformis for $2.27 per share
Restor3d and Conformis (Nasdaq:CFMS) announced that they entered into a definitive merger agreement. Under the agreement, Restor3d, a 3D-printed orthopedic implants company, acquires all outstanding shares of Conformis common stock. The deal includes a purchase price of $2.27 per share. That represents a 96% premium to the closing price on June 22, 2023. Restor3d intends […]
FDA clears patient-specific resection for the Restor3d Axiom total ankle
Restor3d received FDA 510(k) clearance for its Axiom patient-specific resection (PSR) system for use with its Kinos Axiom Total Ankle system. Durham, North Carolina-based Restor3d additively manufactures the Axiom PSR from titanium alloy. The company said this makes it the first all-metal, patient-specific instrumentation system cleared for use with an ankle arthroplasty system. According to […]